ICE Bioscience is pleased to announce its participation in the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place from April 25–30 at McCormick Place Convention Center, Chicago, IL. Visit us at Booth #4138 to explore our latest innovations in oncology drug discovery and preclinical research. This year, ICE Bioscience will present 12 scientific posters across key therapeutic areas, including targeted protein degradation, DNA damage repair, resistant tumor models, and ADC biological evaluation. 

Poster Presentations at AACR 2025 

VAV1-Induced Proximity: Insights from Molecular Glue Profiling 

Unique Breast Cancer CDX Panels for KAT6, ER, and CDK4/6 

Targeting G Protein-Coupled Receptors in Cancer Pharmacotherapy: A Comprehensive Screening Platform 

Specific BaF3 Tumor Platform for c-KIT and KRAS Mutations 

Preclinical Biological Screening and Evaluation of KRAS Molecular Glues 

Novel WRN Drug-Resistant CDX Models 

LC-HRMS-Based Label-Free Screening Platform for Covalent Inhibitors

Establishment and Characterization of Enzalutamide-Resistant Prostate CDX Models 

Comparative Analysis of WRN Inhibitors and DHX9 Inhibitor in a Cancer Cell Panel: Insights into MSI-Dependent Drug Responses 

Celastrol-Cu Nanoparticles Induce Self-Amplified Cuproptosis-Augmented Cancer Immunotherapy 

Advancing HER2-Targeted ADC Drug Discovery through Resistant Cell Line Generation and Cancer Cell Panel Analysis 

A Payload Screening and ADC Evaluation Platform for STING Agonist Antibody–Drug Conjugates

These posters reflect ICE Bioscience's commitment to delivering target-specific, translationally relevant solutions in oncology discovery and development. 

AACR On-Site Promotion: ICECP 170 Cancer Cell Panel™ Discount 

As part of our AACR presence, we're offering a limited-time on-site promotion for our flagship screening platform: ICECP 170 Cancer Cell Panel™ – A predefined cancer cell panel with 170 lines across 21 tumor types, enabling indication discovery, sensitivity profiling, and mechanism-of-action analysis across diverse modalities.